People · Operator
Named in public records as an officer, director or promoter · active 2016–2023 · Biotechnology, Software / Tech
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Rift Biotherapeutics, Inc. | — | Biotechnology | Seed | $2.1M | $94.6M | 2017 |
| SalvaRx Group plc | — | Biotechnology | Pre-Seed | $340K | $18.8M | 2016 |
| Gentian Technologies, Inc. | — | Software / Tech | Pre-Seed | $250K | $1.9M | 2023 |
Ian Walters at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Ian Walters on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Daniel White | 1 | 10 |
| James Mellon | 1 | 10 |
| Briggs Morrison | 1 | 8 |
| Gregory Bailey | 1 | 8 |
| Miguel De Los Rios | 1 | 3 |
| Kamlesh Shah | 1 | 2 |
| Jill Bentley | 1 | 1 |
| Richard Armstrong | 1 | 1 |
| Colin Weinberg | 1 | 1 |
| Thomas Fenal | 1 | 1 |
| Karen Day | 1 | 1 |
| Cornelia Bentley | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.